BECTON DICKINSON & CO (BDX) vs Medline Inc. (MDLN)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | BDX | MDLN |
|---|---|---|
| Sector | Health Care | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $21.84B | $28.43B |
| Revenue growth (YoY) | ▲ 8.2% | — |
| Net income | $1.68B | $1.16B |
| Gross margin | 45.4% | 26.4% |
| Diluted EPS | $5.82 | -$0.01 |
| Insider net (6 mo) | +20.2K sh • 11 sells • 0 buys | −960.8M sh • 86 sells • 1 buys |
| Institutional owners | 54 | 56 |
| Institutional value held | $26.89B | $14B |
| Next earnings (est.) | Around Feb 8, 2027 | Around Feb 24, 2027 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About BECTON DICKINSON & CO (BDX)
Becton, Dickinson and Company (BD) is a global medical technology company, incorporated in New Jersey in 1906 as successor to a New York business started in 1897. Read more →
About Medline Inc. (MDLN)
Medline Inc. is the largest provider of medical-surgical (med-surg) products and supply chain solutions serving all points of care, based on total net sales of med-surg products. Read more →
Source: SEC EDGAR.